News

AstraZeneca fends off diabetes generic, for now ...
Pharma giant dodges threat as US judge dismisses monopoly claims over its blockbuster cancer drug | FDA approves new ...
The Düsseldorf court’s decision offers an instructive perspective on the legal nature of patent pledges as well as a reminder ...
Ahead of the upcoming LSPN North America-Spring 2025 conference, chair Eldora Ellison shares insights on emerging innovations ...
EPO: Biotech innovation strong, while pharma trails behind ...
The court hands Edwards Lifesciences a win in its long-running battle with Meril | Panel issues a second Europe-wide ...
Miami-based hire brings experience in patent litigation and portfolio management, having previously worked on drug cases ...
To request a FREE 2-week trial subscription, please signup. NOTE - this can take up to 48hrs to be approved.
The IP specialist bypassed vendors and turned to its own ‘tech geeks’ to create an in-house AI solution for drafting patent ...
Lawsuits against pharmacies in seven states aim to protect its flagship Mounjaro and Zepbound medications | Growing ...